Connective Capital Management, LLC
Position in ACTU — Actuate Therapeutics, Inc.
CIK 1543568
PALO ALTO, CA
Position in ACTU
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$310,348
New position
Shares Held
113,266
first reported quarter
Ownership
0.473%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connective Capital Management, LLC holds $1,479,127 across 6 Biotechnology names. ACTU ranks #3 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CBUS |
Cibus, Inc.
|
279,000 | $552,420 | |
| 2 | GRCE |
Grace Therapeutics, Inc.
|
84,549 | $391,461 | |
| 3 | ACTU |
Actuate Therapeutics, Inc.
This page
|
113,266 | $310,348 | |
| 4 | PCSA |
Processa Pharmaceuticals, Inc.
|
70,736 | $178,608 | |
| 5 | OTLK |
Outlook Therapeutics, Inc.
|
200,000 | $41,200 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
1,016 | $5,090 |
All Filings in ACTU
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $310,348 | 113,266 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||